Aktieinformation Bioera | Filter  Basic-Info

Bioera

Bioera's headquarter is based in Milano. Bioera mainly operates in the pharmaceutical sector. Canio Giovanni Mazzaro is leading the company as CEO. The CFO of Bioera the company is Francesca Cesari. The global pharmaceutical companies gained around 75 percent over the period 2006-2016. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-2016) there is a minus of 75 percent.

The past year yielded positive returns for Bioera investors

Over the past year the company' stock lost around 38 percent. The period between August 2011 and August 2016 was a bad period for the investors. The stock lost around 17 percent. Bioera's revenues between 2011 and 2015 were relatively steady and moved between 47,16 million euros and 58,49 million euros. During 2011 and 2015 Bioera's net results were very volatile and fluctuated between 11,36 million euros and 0 million euros.

Over the past 5 years the Italian company paid out dividends. On average Bioera's dividend yield over the past 5 years was around 0,05 percent annually.

Bioera financed with relatively low debt

At the end of 2015 the Italian company's balance sheet was worth 0 million euros. The total debt was around 0 million euros. This is percent of the total balance sheet.

The pharmaceutical company's market capitalization (the number of shares outstanding times the market value) equaled around 0 million euros.

All Bioera's annual reports can be found here. More information about Bioera can be found it's website. .